杨大成 晏菊芳 许 荩 叶飞 周祖文 张蔚瑜 范 莉 陈 欣. 4-(1-芳基-3-氧代-5-苯基戊氨基)苯磺酰胺的合成与抗糖尿病活性初步研究J. 药学学报, 2010,45(1): 66-71.
引用本文: 杨大成 晏菊芳 许 荩 叶飞 周祖文 张蔚瑜 范 莉 陈 欣. 4-(1-芳基-3-氧代-5-苯基戊氨基)苯磺酰胺的合成与抗糖尿病活性初步研究J. 药学学报, 2010,45(1): 66-71.
YANG Da-Cheng, YAN Ju-Fang, HU Jin, XIE Fei, ZHOU Jie-Wen, ZHANG Wei-Yu, FAN Chi, CHEN Xin. Synthesis and investigation on antidiabetic activity of 4-(1-aryl-3-oxo-5-phenylpentylamino) benzenesulfonamideJ. 药学学报, 2010,45(1): 66-71.
Citation: YANG Da-Cheng, YAN Ju-Fang, HU Jin, XIE Fei, ZHOU Jie-Wen, ZHANG Wei-Yu, FAN Chi, CHEN Xin. Synthesis and investigation on antidiabetic activity of 4-(1-aryl-3-oxo-5-phenylpentylamino) benzenesulfonamideJ. 药学学报, 2010,45(1): 66-71.

4-(1-芳基-3-氧代-5-苯基戊氨基)苯磺酰胺的合成与抗糖尿病活性初步研究

Synthesis and investigation on antidiabetic activity of 4-(1-aryl-3-oxo-5-phenylpentylamino) benzenesulfonamide

  • 摘要:

    采用分段投料法, 通过Mannich反应直接合成了12个含有磺胺的β-氨基酮化合物, 收率23%97%。所制备的新化合物采用FTIRESI-MS1H NMR13C NMRHR-MS等方法进行结构确证。初步抗糖尿病活性筛选结果显示, 所合成的含有磺胺的β-氨基酮化合物具有不同程度的抗糖尿病活性, 其中目标分子1e具有较好的α-葡萄糖苷酶抑制活性, 1l表现出较好的过氧化物酶体增殖物激活受体反应元件 (PPRE) 激动活性。在此基础上, 讨论了所得化合物的构效关系

     

    Abstract:

    Searching for new antidiabetic lead compound, 4-(1-aryl-3-oxo-5-phenylpentylamino) benzenesulfonamides were designed and synthesized directly by three component one-pot condensation of 4-phenyl- 2-butanone and sulfanilamide with some aromatic aldehydes at an yield of 23%−97%.  The chemical structures of the twelve new Mannich bases were confirmed by 1H NMR, 13C NMR, FTIR, ESI-MS and HR-MS.  The screening results of antidiabetic activity indicated that most of these title compounds possess α-glucosidase   inhibitory activity, among which compound 1e is the strongest one.  And compound 1l possesses good peroxisome proliferator-activated receptor response element (PPRE) agonist activity.  The structure-activity relationship of these new β-amino ketones containing benzenesulfonamide unit was also discussed preliminarily.

     

/

返回文章
返回